Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate Effects on Brain Activity During Stop Signal Task
NCT02453698Phase 1Completed
- Sponsor
- SickKids
- Start
- Jan 2011
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of methylphenidate hydrochloride extended-release chewable tablet in attention deficit hyperactivity disorder (ADHD), sponsored by SickKids. Primary endpoint: Neural activity assessed using fMRI at 7 days. Started Jan 2011; status: completed.
02
Drugs
methylphenidate hydrochloride extended-release chewable tablet
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT02453698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02453698.